Protein expression
Ended Purchase Order Awarded Last action
- Contract number
- 75N93018P01318
- Awardee
-
Genscript USA Inc. UEI KVLBRRAQ6UX1
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $149,680
Award facts
- Opportunity
-
- Cloning, Gene synthesis, and Proteins/Antibodies Pre-Solicitation · NIAIDNOI181922325 · Posted Aug 30, 2018
- Contract value 100% obligated
- $149,680.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Piscataway, NJ 08854, USA
Award details come from SAM.gov/FPDS.
About this award
The National Institute of Allergy and Infectious Diseases awarded a purchase order to Genscript USA Inc. for $149,680.00 on September 12, 2018, for protein expression services.
Work is performed in Piscataway, New Jersey. The order carries a firm fixed price structure under a pre-solicitation opportunity that closed September 5, 2018. Ultimate completion is scheduled for September 16, 2019.
Quick answers
Who was awarded contract 75N93018P01318?
75N93018P01318 was awarded to Genscript USA Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 12, 2018.
How much is contract 75N93018P01318 worth?
The government has obligated $149,680 on 75N93018P01318.
Was contract 75N93018P01318 competed?
The extent of competition for 75N93018P01318 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award